Singh K, Gillett S, Ireson J, Hills A, et al. M-EA (methotrexate, etoposide, dactinomycin) and EMA-CO (methotrexate, etoposide, dactinomycin / cyclophosphamide, vincristine) regimens as first line treatment of high-risk Gestational Trophoblastic Neoplasia. Int J Cancer 2020 Nov 19. doi: 10.1002/ijc.33403.
PMID: 33210289